E‐E Ke

Distribution and prognosis of uncommon metastases from non-small cell lung cancer

Feiyu Niu, Qing Zhou, Jin‐Ji Yang et al. · BMC Cancer · 2016 · 165 citations · Full text

Medicine, Oncology, Pathology +13

A Higher Proportion of the EGFR T790M Mutation May Contribute to the Better Survival of Patients with Exon 19 Deletions Compared with Those with L858R

E‐E Ke, Qing Zhou, Qiuyi Zhang et al. · Journal of Thoracic Oncology · 2017 · 95 citations · Full text

Medicine, Genetics, Oncology +7

EGFR L792H and G796R: Two Novel Mutations Mediating Resistance to the Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib

Qi Zhang, Xu‐Chao Zhang, Jin‐Ji Yang et al. · Journal of Thoracic Oncology · 2018 · 77 citations · Full text

Medicine, Oncology, Pharmacology +14

Circulating Tumor DNA-Guided De-Escalation Targeted Therapy for Advanced Non−Small Cell Lung Cancer

Song Dong, Zhen Wang, Jia‐Tao Zhang et al. · JAMA Oncology · 2024 · 65 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial

Si‐Yang Maggie Liu, Jie Huang, Jia‐Yi Deng et al. · Science Bulletin · 2023 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17